RxDoctor Payments DataLook up a doctor →

Sarah Smiley, DO

Hospitalist · Austin, TXNPI 1386672129

Payments from drug & device makers

$19,850,244in general payments, 2019–2025

Across 4,461 payments — averaging $4449.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$7.4M
  • GSK$3.5M
  • AstraZeneca$1.3M
  • Pfizer$1.1M
  • Seqirus USA Inc$913K
  • Vertex$861K
  • plus $4.7M from 34 others
$65,770in research payments, 2019–2025

Across 12 payments — averaging $5480.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Valneva Austria GmbH$33K
  • Eli Lilly$29K
  • Chiesi USA, Inc.$2K
  • GSK$839

What the payments were for

  • Speaking & faculty fees$83,25092%
  • Travel & lodging$5,2336%
  • Food & beverage$1,9022%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,850,244 in reported general payments places this provider in the 95th percentile of 1,284 hospitalist providers in Texas.

See all hospitalist providers in Texas

Medicare billing

Part B allowed, 2024
$11,426
Medicare patients
67
Services billed
105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin129$890
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$290
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$124

Paid to pharmacies, not to this prescriber.

Other hospitalist in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →